The relationship between prognostic and predictive factors in the management of breast cancer.
about
The pathology of familial breast cancer: Immunohistochemistry and molecular analysisIdentifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomesIncidence of breast cancer in the United States: current and future trends.A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genesCurrent status of the prognostic molecular biomarkers in breast cancer: A systematic reviewInferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.How many etiological subtypes of breast cancer: two, three, four, or more?Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.Long-term prognostic role of functional limitations among women with breast cancerCost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.Ethics in sentinel node biopsy in breast cancer: an open question.Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trialNanotechnology for early cancer detection.Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancerProliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives.A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients.Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcomeCompeting causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.Triple-negative breast cancer: present challenges and new perspectives.Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trials.Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.Trial assessing individualized options for treatment for breast cancer: the TAILORx trial.Predictive tests for individualization of pharmacological cancer treatment.Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens.Conventional and new emerging prognostic factors in breast cancer: an update.Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.Histolopathologic approach to direct the management of the axilla in early breast cancer patients.A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.Classification Models for Breast Cancer Molecular Subtyping: What is the Best Candidate for a Translation into Clinic?
P2860
Q24800411-18F04D10-EC22-4E8A-BAC3-CC6D4CB0C1FEQ26778675-C88C0BB9-3D81-4B66-B32C-8BC05F8B9B44Q30504517-12D22650-D534-457B-AD6D-909B0438D681Q30566202-F3FA2565-A360-4E23-BA24-D915B77CA4BDQ33598494-E8A56A70-EFBB-40F1-8115-3D5B1BB90621Q33605369-78B0E5F6-4908-4033-BE1F-360E8BC6E026Q33751139-4FEA148A-961A-45ED-95C6-94F693D450DAQ34106175-BF5C58CA-4203-4588-BFD5-AB1E876C93E7Q34166938-CEFD057C-6619-4F11-99E7-435229C49765Q34176406-EE5AABBA-5D66-4831-BDDA-E33F19E56CDFQ34431985-55B38F02-CC07-4A6C-9364-E2C069F4C254Q34722692-3146C10B-9AE3-4FFE-85B7-221A3699945FQ35114439-F7E0CF44-19FE-4970-8266-5474543B7CC7Q35584284-8D156F93-13F8-48A5-8337-8DB48D599F31Q35727150-9828A5AF-4631-4DC1-8F66-D9764A01F920Q35854297-F953C082-BACB-4B12-A371-A594130B2CD3Q36175746-85EA30AA-A058-4FB0-B6B9-F830360E6530Q36194948-A83CFDC7-7D7E-4199-8BB7-56B66F62F8B7Q36239218-EBB5FB04-A6A1-4378-B4E8-85C05A41B049Q36670928-8F141D6B-3176-4F2C-B84A-1F85323E38BDQ37350526-9F7FFA77-EA4F-4137-8E5F-34613CCA9679Q37689699-EAA7D226-9854-4937-858A-3D045E0CB2CBQ37764168-DE034603-B598-4205-90D6-5DB46D63E643Q37969774-A5426CA1-E0CB-4448-949A-359ED73738E0Q38734026-DE2C5CA4-FDCF-4AB4-A07C-871A753A32D9Q38849205-EC4C168E-0E7A-4810-9145-2A3BAAA25831Q39674037-EBC9CB68-A7F5-4B9B-9C94-7F256937C5CEQ40036322-E90AD48D-F629-4149-8CC4-71AD685C4AA3Q40109282-879F7A91-0162-4F94-BBB4-AB3451C36F80Q40655374-B9FD32AE-1BA4-4160-87AA-CE883BAFE949Q43061623-E0B11FFE-32E9-4073-8524-BE1870A25FE7Q43132680-E4982E79-08A0-49BE-BED2-1463B8D51660Q46892337-535C76EE-BBF3-4CA1-81A8-CC8300E9CD06Q48875025-00B72ACD-0846-4FA5-B87B-535B9FAA67A5Q54058828-9B6D63BD-2D78-4C65-9A12-006B7CCAD16EQ54230919-5FE92441-AC74-41A1-A25C-E92C9D4DE553Q55071512-12929D67-DDCC-4DDF-93CA-7EDA5BA71827Q57660150-96461279-B24E-4E81-A539-A2E42EA1D589
P2860
The relationship between prognostic and predictive factors in the management of breast cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The relationship between progn ...... e management of breast cancer.
@ast
The relationship between progn ...... e management of breast cancer.
@en
The relationship between progn ...... e management of breast cancer.
@nl
type
label
The relationship between progn ...... e management of breast cancer.
@ast
The relationship between progn ...... e management of breast cancer.
@en
The relationship between progn ...... e management of breast cancer.
@nl
prefLabel
The relationship between progn ...... e management of breast cancer.
@ast
The relationship between progn ...... e management of breast cancer.
@en
The relationship between progn ...... e management of breast cancer.
@nl
P2860
P356
P1476
The relationship between progn ...... e management of breast cancer.
@en
P2093
Henderson IC
P2860
P2888
P304
P356
10.1023/A:1006141703224
P407
P577
1998-01-01T00:00:00Z
P6179
1039661694